Although liver expression of PPARγ is relatively low in basal conditions, its expression is upregulated in fatty liver diseases such as NAFLD, where it induces de novo lipogenesis and lipid accumulation [19]. This evidence concerns the gene PPARG and metabolic dysfunction-associated steatotic liver disease.